Aravive Analyst Ratings
Aravive Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/03/2023 | — | BTIG | Downgrades | Buy → Neutral | |
| 07/21/2023 | 1311.76% | Cantor Fitzgerald | → $18 | Reiterates | Overweight → Overweight |
| 07/17/2023 | 1311.76% | Cantor Fitzgerald | → $18 | Reiterates | Overweight → Overweight |
| 07/10/2023 | 1311.76% | Cantor Fitzgerald | → $18 | Reiterates | Overweight → Overweight |
| 07/03/2023 | 1311.76% | Cantor Fitzgerald | $18 → $18 | Reiterates | Overweight → Overweight |
| 06/05/2023 | 841.18% | HC Wainwright & Co. | → $12 | Reiterates | Buy → Buy |
| 06/05/2023 | 684.31% | EF Hutton | → $10 | Reiterates | Buy → Buy |
| 05/26/2023 | 684.31% | EF Hutton | → $10 | Reiterates | Buy → Buy |
| 05/26/2023 | 841.18% | HC Wainwright & Co. | → $12 | Reiterates | Buy → Buy |
| 05/25/2023 | 684.31% | EF Hutton | → $10 | Reiterates | Buy → Buy |
| 05/25/2023 | 841.18% | HC Wainwright & Co. | → $12 | Reiterates | Buy → Buy |
| 05/17/2023 | 1311.76% | Cantor Fitzgerald | → $18 | Reiterates | Overweight → Overweight |
| 05/11/2023 | 684.31% | EF Hutton | → $10 | Reiterates | Buy → Buy |
| 05/11/2023 | 841.18% | HC Wainwright & Co. | → $12 | Reiterates | Buy → Buy |
| 03/16/2023 | 841.18% | HC Wainwright & Co. | $7 → $12 | Maintains | Buy |
| 02/21/2023 | 449.02% | HC Wainwright & Co. | → $7 | Reiterates | → Buy |
| 02/14/2023 | 684.31% | EF Hutton | → $10 | Maintains | Buy |
| 01/05/2023 | 684.31% | EF Hutton | → $10 | Initiates Coverage On | → Buy |
| 11/14/2022 | 56.86% | Piper Sandler | $6 → $2 | Maintains | Overweight |
| 10/25/2022 | 449.02% | HC Wainwright & Co. | $26 → $7 | Maintains | Buy |
| 06/03/2022 | 1076.47% | Roth Capital | → $15 | Initiates Coverage On | → Buy |
| 03/08/2021 | 1939.22% | BTIG | → $26 | Initiates Coverage On | → Buy |
| 09/18/2020 | — | William Blair | Initiates Coverage On | → Outperform | |
| 07/23/2020 | 1939.22% | HC Wainwright & Co. | $15 → $26 | Maintains | Buy |
| 03/27/2020 | 1076.47% | HC Wainwright & Co. | $25 → $15 | Maintains | Buy |
| 12/20/2019 | 1860.78% | HC Wainwright & Co. | $31 → $25 | Maintains | Buy |
| 12/10/2019 | 2252.94% | Cantor Fitzgerald | → $30 | Initiates Coverage On | → Overweight |
| 11/20/2019 | 2331.37% | HC Wainwright & Co. | $18 → $31 | Reiterates | → Buy |
| 11/19/2019 | 2723.53% | Piper Sandler | $15 → $36 | Maintains | Overweight |
| 10/10/2019 | 1311.76% | HC Wainwright & Co. | → $18 | Initiates Coverage On | → Buy |
| 05/13/2019 | 684.31% | Piper Sandler | → $10 | Initiates Coverage On | → Overweight |
| 04/09/2019 | 998.04% | Wedbush | → $14 | Initiates Coverage On | → Outperform |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 08/03/2023 | - | BTIG | 評級下調 | 購買→中性 | |
| 07/21/2023 | 1311.76% | 康託·菲茨傑拉德 | →$18 | 重申 | 超重→超重 |
| 07/17/2023 | 1311.76% | 康託·菲茨傑拉德 | →$18 | 重申 | 超重→超重 |
| 07/10/2023 | 1311.76% | 康託·菲茨傑拉德 | →$18 | 重申 | 超重→超重 |
| 07/03/2023 | 1311.76% | 康託·菲茨傑拉德 | $18→$18 | 重申 | 超重→超重 |
| 06/05/2023 | 841.18% | HC Wainwright公司 | →$12 | 重申 | 購買→購買 |
| 06/05/2023 | 684.31% | EF Hutton | →$10 | 重申 | 購買→購買 |
| 2023年05月26日 | 684.31% | EF Hutton | →$10 | 重申 | 購買→購買 |
| 2023年05月26日 | 841.18% | HC Wainwright公司 | →$12 | 重申 | 購買→購買 |
| 2023年05月25日 | 684.31% | EF Hutton | →$10 | 重申 | 購買→購買 |
| 2023年05月25日 | 841.18% | HC Wainwright公司 | →$12 | 重申 | 購買→購買 |
| 2023年05月17日 | 1311.76% | 康託·菲茨傑拉德 | →$18 | 重申 | 超重→超重 |
| 2023年05月11日 | 684.31% | EF Hutton | →$10 | 重申 | 購買→購買 |
| 2023年05月11日 | 841.18% | HC Wainwright公司 | →$12 | 重申 | 購買→購買 |
| 03/16/2023 | 841.18% | HC Wainwright公司 | $7→$12 | 維護 | 買 |
| 02/21/2023 | 449.02% | HC Wainwright公司 | →$7 | 重申 | →購買 |
| 02/14/2023 | 684.31% | EF Hutton | →$10 | 維護 | 買 |
| 01/05/2023 | 684.31% | EF Hutton | →$10 | 開始承保 | →購買 |
| 2022年11月14日 | 56.86% | 派珀·桑德勒 | $6→$2 | 維護 | 超重 |
| 2022年10月25日 | 449.02% | HC Wainwright公司 | $26→$7 | 維護 | 買 |
| 06/03/2022 | 1076.47% | 羅斯資本 | →$15 | 開始承保 | →購買 |
| 03/08/2021 | 1939.22% | BTIG | →$26 | 開始承保 | →購買 |
| 09/18/2020 | - | 威廉·布萊爾 | 開始承保 | →跑贏大盤 | |
| 07/23/2020 | 1939.22% | HC Wainwright公司 | $15→$26 | 維護 | 買 |
| 03/27/2020 | 1076.47% | HC Wainwright公司 | $25→$15 | 維護 | 買 |
| 2019年12月20日 | 1860.78% | HC Wainwright公司 | $31→$25 | 維護 | 買 |
| 2019年12月10日 | 2252.94% | 康託·菲茨傑拉德 | →$30 | 開始承保 | →超重 |
| 2019年11月20日 | 2331.37% | HC Wainwright公司 | $18→$31 | 重申 | →購買 |
| 2019年11月19日 | 2723.53% | 派珀·桑德勒 | $15→$36 | 維護 | 超重 |
| 2019年10月10日 | 1311.76% | HC Wainwright公司 | →$18 | 開始承保 | →購買 |
| 2019年05月13日 | 684.31% | 派珀·桑德勒 | →$10 | 開始承保 | →超重 |
| 2019年09月04日 | 998.04% | 韋德布什 | →$14 | 開始承保 | →跑贏大盤 |
What is the target price for Aravive (ARAV)?
Aravive(ARAV)的目標價是多少？
The latest price target for Aravive (NASDAQ: ARAV) was reported by BTIG on August 3, 2023. The analyst firm set a price target for $0.00 expecting ARAV to fall to within 12 months (a possible -100.00% downside). 20 analyst firms have reported ratings in the last year.
BTIG於2023年8月3日報道了Aravive(納斯達克：ARIV)的最新目標價。這家分析公司將目標價定為0.00美元，預計ARAV值將在12個月內下降(跌幅可能為-100.00%)。去年，已有20家分析公司公佈了評級。
What is the most recent analyst rating for Aravive (ARAV)?
分析師對Aravive(ARAV)的最新評級是多少？
The latest analyst rating for Aravive (NASDAQ: ARAV) was provided by BTIG, and Aravive downgraded their neutral rating.
納斯達克(Sequoia Capital：ARIV)的最新分析師評級是由巴克萊國際提供的，Aravive下調了其中性評級。
When is the next analyst rating going to be posted or updated for Aravive (ARAV)?
Aravive(ARAV)的下一次分析師評級將於何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Aravive, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Aravive was filed on August 3, 2023 so you should expect the next rating to be made available sometime around August 3, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括查閱公共財務報表，與Aravive的高管和客戶交談，以及聽取收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。Aravive的上一次評級是在2023年8月3日提交的，所以你應該預計下一次評級將在2024年8月3日左右提供。
Is the Analyst Rating Aravive (ARAV) correct?
分析師對Aravive(ARAV)的評級正確嗎？
While ratings are subjective and will change, the latest Aravive (ARAV) rating was a downgraded with a price target of $0.00 to $0.00. The current price Aravive (ARAV) is trading at is $1.27, which is out of the analyst's predicted range.
雖然評級是主觀的，而且會發生變化，但最新的Aravive(ARAV)評級被下調，目標價在0.00美元至0.00美元之間。Aravive(ARAV)目前的交易價格為1.27美元，超出了分析師的預測區間。